These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23706183)

  • 21. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases.
    Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
    Radiother Oncol; 1990 May; 18(1):9-17. PubMed ID: 2163064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical prognostic factors of adult supratentorial glioblastoma].
    Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
    Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.
    Field KM; Drummond KJ; Yilmaz M; Tacey M; Compston D; Gibbs P; Rosenthal MA
    J Clin Neurosci; 2013 Jun; 20(6):783-9. PubMed ID: 23639619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astroblastomas: a Surveillance, Epidemiology, and End Results (SEER)-based patterns of care analysis.
    Ahmed KA; Allen PK; Mahajan A; Brown PD; Ghia AJ
    World Neurosurg; 2014; 82(1-2):e291-7. PubMed ID: 24141003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma multiforme-report of 267 cases treated at a single institution.
    Stark AM; Nabavi A; Mehdorn HM; Blömer U
    Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
    McLendon RE; Halperin EC
    Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and pathogenesis of cerebellar glioblastoma.
    Takahashi Y; Makino K; Nakamura H; Hide T; Yano S; Kamada H; Kuratsu J
    Mol Med Rep; 2014 Nov; 10(5):2383-8. PubMed ID: 25199771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
    Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
    Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
    Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
    Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
    Zinn PO; Colen RR; Kasper EM; Burkhardt JK
    Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.